Chylous ascites following retroperitoneal lymphadenectomy in gynecologic malignancies: Incidence, risk factors and management

dc.contributor.authorSolmaz, Ulas
dc.contributor.authorTuran, Volkan
dc.contributor.authorMat, Emre
dc.contributor.authorDereli, Murat Levent
dc.contributor.authorEkin, Atalay
dc.contributor.authorPeker, Nuri
dc.contributor.authorSanci, Muzaffer
dc.date.accessioned2026-08-12T18:12:26Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractIntroduction: Chylous ascites is a rare form of ascites that results from accumulated lymph fluid in the peritoneal cavity caused by blocked or disrupted lymph flow through the major lymphatic channels. In the present study, our aim was to analyze the incidence, risk factors, diagnostic evaluation and management of chylous ascites after lymphadenectomy in gynecologic malignancies. Methods: A total of 458 patients who had undergone staging surgery for gynecologic malignancies at our institution between January 2010 and December 2013 were retrospectively reviewed. After the exclusion criteria were applied, 399 patients were divided into 2 groups based on the presence (n = 36) or absence (n = 363) of chylous ascites. Results: Among the 399 patients, 36 (9%) developed chylous ascites. The median time to onset was 4 days (range, 2e7 days). The analysis of the various features of lymphadenectomy showed that the number of para-aortic lymph nodes (PALNs) removed was significantly greater in the patients with chylous ascites (p < 0.001). A cut-off value of > 14 PALNs was a good predictor of chylous ascites. In all patients, chylous ascites resolved with conservative management. Conclusions: Postoperative chylous ascites was strongly associated with the number of harvested PALNs. According to our findings, we suggest that conservative treatment should be the first step in managing patients with chylous ascites. Using an abdominal drain after surgery seems to be an effective diagnostic tool and treatment method for chylous ascites. (C) 2015 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
dc.identifier.doi10.1016/j.ijsu.2015.02.020
dc.identifier.endpage93
dc.identifier.issn1743-9191
dc.identifier.issn1743-9159
dc.identifier.orcid0000-0002-9602-9099
dc.identifier.orcid0000-0002-4854-3851
dc.identifier.orcid0000-0002-4712-3927
dc.identifier.orcid0000-0002-8494-4302
dc.identifier.pmid25765351
dc.identifier.startpage88
dc.identifier.urihttps://doi.org/10.1016/j.ijsu.2015.02.020
dc.identifier.urihttps://hdl.handle.net/11508/63881
dc.identifier.volume16
dc.identifier.wosWOS:000352298000017
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.ispartofInternational Journal of Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectChylous ascites
dc.subjectGynecologic malignancy
dc.subjectLymphadenectomy
dc.subjectDrain
dc.subjectConservative treatment
dc.titleChylous ascites following retroperitoneal lymphadenectomy in gynecologic malignancies: Incidence, risk factors and management
dc.typeArticle

Dosyalar